Leading the way to early diagnosis.


The damage to joints caused by RA is irreversible. We are focused on identifying biomarkers to diagnose RA at the onset of the disease to avoid joint erosions and other damage. QUANTA Flash® and QUANTA Lite® CCP3 assays aid in the early diagnosis of this disease, where prompt initiation of treatment can greatly benefit patients.

VOORDELEN
  • Giving patients earlier answers.
    We help improve patient care by providing tests that can aid in the early diagnosis of RA for prompt treatment.
  • Accurate lab results.
    Labs feel good knowing that our RA assays aid in early disease detection while delivering highly accurate results.
  • Bringing clinicians more options.
    Clinicians appreciate our research into new biomarkers that may provide additional insight into diagnosis, prognosis and disease activity monitoring for RA.

Reagentia


Beschrijving
Pakketgrootte
Onderdeel nummer
Documents
QUANTA Lite® RF IgA
1 X 96 wells
708695
QUANTA Lite® RF IgG
1 X 96 wells
708685
QUANTA Lite® RF IgM
1 X 96 wells
708690

QUANTA Lite® CCP3 IgG

1 X 96 wells
704535

QUANTA Lite® CCP3.1 IgG/IgA

1 X 96 wells
704550
Beschrijving
Pakketgrootte
Onderdeel nummer
Documents

QUANTA Flash® CCP3

Utilization pour le diagnostic in vitro / Marquage CE
701125

QUANTA Flash® RF IgM

100 tst
701340

QUANTA Flash® RF IgA

100 tst
701345